Qinghai Spring Medicinal Resources Technology Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 103.22 million compared to CNY 102.77 million a year ago. Revenue was CNY 107.42 million compared to CNY 105.39 million a year ago.

Net loss was CNY 50.59 million compared to CNY 48.94 million a year ago. Basic loss per share from continuing operations was CNY 0.086 compared to CNY 0.083 a year ago. Diluted loss per share from continuing operations was CNY 0.086 compared to CNY 0.083 a year ago.